BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23969530)

  • 21. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
    Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
    Peng J; Mo R; Ma J; Fan J
    World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression.
    Park SY; Kim JH; Lee YJ; Lee SJ; Kim Y
    Int J Oncol; 2013 Jan; 42(1):287-96. PubMed ID: 23151889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Chinese medicine formula Gegen Qinlian decoction suppresses expansion of human renal carcinoma with inhibition of matrix metalloproteinase-2.
    Wang N; Feng Y; Cheung F; Wang X; Zhang Z; Feng Y
    Integr Cancer Ther; 2015 Jan; 14(1):75-85. PubMed ID: 25228536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
    Morais C; Pat B; Gobe G; Johnson DW; Healy H
    Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
    Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH
    Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H; Hara I; Gohji K; Yamanaka K; Hara S; Arakawa S; Nakajima M; Kamidono S
    Clin Cancer Res; 1999 Oct; 5(10):2824-9. PubMed ID: 10537348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
    Wang X; Nagase H; Watanabe T; Nobusue H; Suzuki T; Asami Y; Shinojima Y; Kawashima H; Takagi K; Mishra R; Igarashi J; Kimura M; Takayama T; Fukuda N; Sugiyama H
    Cancer Sci; 2010 Mar; 101(3):759-66. PubMed ID: 20085585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-α-induced human renal carcinoma cell invasion.
    Jin M; Xiao R; Wang J; Liu X; Liu Y; Xue Z; Lv L; Zheng Y; Li Q
    Acta Biochim Biophys Sin (Shanghai); 2013 May; 45(5):377-82. PubMed ID: 23435195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.
    Lin YW; Lee LM; Lee WJ; Chu CY; Tan P; Yang YC; Chen WY; Yang SF; Hsiao M; Chien MH
    J Pineal Res; 2016 Apr; 60(3):277-90. PubMed ID: 26732239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sprouty2 is associated with prognosis and suppresses cell proliferation and invasion in renal cell carcinoma.
    Li P; Tao L; Yang J; Cai H; Ju X; Li J; Shao P; Cao Q; Qin C; Meng X; Yin C
    Urology; 2013 Jul; 82(1):253.e1-7. PubMed ID: 23688375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma.
    Goelden U; Pfoertner S; Hansen W; Toepfer T; von Knobloch R; Hofmann R; Buer J; Schrader AJ
    Urol Int; 2005; 75(3):269-76. PubMed ID: 16215318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
    Huang CS; Fan YE; Lin CY; Hu ML
    J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G
    Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.